BofA Securities Downgrades 10X Genomics (TXG) to Underperform

July 15, 2022 6:05 AM EDT
Get Alerts TXG Hot Sheet
Price: $46.14 +1.70%

Rating Summary:
    8 Buy, 1 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 15 | New: 17
Join SI Premium – FREE

BofA Securities analyst Derik de Bruin downgraded 10X Genomics (NASDAQ: TXG) from Neutral to Underperform with a price target of $35.00 (from $80.00).

For an analyst ratings summary and ratings history on 10X Genomics click here. For more ratings news on 10X Genomics click here.

Shares of 10X Genomics closed at $43.29 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades, Hot Downgrades